Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Gottlieb says vaccination strategy “doesn’t work” and US should “push reset button”

Gottlieb says vaccination strategy “doesn’t work” and US should “push reset button”



Washington – Dr Scott Gottlieb, former director of the Food and Drug Administration, said on Sunday that the national strategy for administration coronavirus vaccines “don’t work” and encouraged public health officials to “hit reset” and adopt a new approach to inoculating Americans more quickly.

“We really need to get this vaccine faster, because it’s really our only tool, our only precaution against the spread of these new variants. If we can get a lot of people to get vaccinated quickly, we can get enough protective immunity among population that it stops spreading at the rate it is, “Gottlieb said in an interview with”

; Face the Nation. “So, we have to admit it doesn’t work. We need to achieve resetting and adopt a new strategy, trying to reach out to patients. “

The spread of the two coronavirus vaccines, from Pfizer and Germany’s BioNTech and Moderna, has hit as already stretched hospitals and health services face staff shortages and logistics problems. With the vaccine being offered to older Americans and health care workers, some hospital systems have begun offering incentives of workers to get their pictures.

According to the Centers for Disease Control and Prevention, 22.1 million doses of vaccines have been distributed and nearly 6.7 million people have received the first of the two doses. To speed up the spread of vaccines, President-elect Joe Biden plans to do so release all available doses instead of holding back the supply of vaccines, as the Trump administration has done since taking office.

Gottlieb also offered to release all available supplies, and last week said state leaders should consider taking pictures of the coronavirus. more widely available for people aged 65 and over.

“There are currently 40 million doses on the shelf. So the federals say it’s with the states. The states say it’s with the federal ones. It really doesn’t matter to the patient who doesn’t have access to the injection,” he repeated on Sunday. “You have 40 million on the shelf. We have 50 million Americans over the age of 65. So we have supplies to push it toward that population more aggressively.”

Gottlieb said the government must adopt the “entirely above approach” and push vaccines through a variety of channels, including major stores and federal sites.

“We have to try everything right now to create a lot of distribution points,” he said. “Many senior citizens will not want to go to, you know, a stadium to get an inoculation. They will want to go to a pharmacy, a local pharmacy or a doctor’s office. So, we need to give people more opportunities to get vaccinated there. where it’s convenient for them to get it. But we need to get them out more aggressively. “

While the current problem of vaccinations is spreading, Gottlieb will become a supply problem once the logistics are improved.

“We are not doing a good job of providing this to patients,” he said.

There are more than 22.1 million confirmed cases of coronavirus in the United States and more than 372,000 people have died from COVID-19, according to Johns Hopkins University. The number of infections is expected to decline this month after the post-holiday jump, but new variants of the coronavirus have been discovered in the United Kingdom and South Africa.

Gottlieb said the new strains are unlikely to contribute much to the current jump in the United States and predicted that the UK option is approximately 0.2% to 0.3% of infections here, although he said the country is not sequencing large enough. scale to detect options.

“We don’t think these new options are currently contributing to the increase in infection we’re seeing,” he said. “We think it’s a post-holiday rebound, but most importantly, we need a better system to detect these things so we can have an adequate public health response.”

Gottlieb said the viruses would evolve, so vaccines, antibody drugs and other therapies would need to be updated regularly to keep up with new options.

“This virus is moving around the world, all over the world, competing around the world largely uncontrollably,” he said. “He’s been under some sort of selective pressure with widespread use, for example, of convalescent plasma. So it’s inevitable to see these kinds of mutations in this virus. And it’s probably going to be a constant struggle.”


Source link